AAAAAA
Results: 1-25/40
Authors:
TRIPLETT DA
Citation: Da. Triplett, ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES - A PARADIGM FOR ANTIBODY-MEDIATED THROMBOSIS, Journal of clinical ligand assay, 21(2), 1998, pp. 214-217
Authors:
TRIPLETT DA
Citation: Da. Triplett, MANY FACES OF LUPUS ANTICOAGULANTS, Lupus, 7, 1998, pp. 18-22
Authors:
YAMAZAKI M
ASAKURA H
SAITO M
JOKAJI H
UOTANI C
KUMABASHIRI I
MORISHITA E
AOSHIMA K
MATSUDA T
TRIPLETT DA
Citation: M. Yamazaki et al., PROTHROMBIN FRAGMENT 1+2 MEASURES TREATMENT EFFECT IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, Thrombosis research, 91(3), 1998, pp. 121-128
Authors:
TANNE D
TRIPLETT DA
LEVINE SR
Citation: D. Tanne et al., ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES AND ISCHEMIC STROKE NOT JUST CARDIOLIPIN ANY MORE, Stroke, 29(9), 1998, pp. 1755-1758
Authors:
TRIPLETT DA
Citation: Da. Triplett, CURRENT RECOMMENDATIONS FOR WARFARIN THERAPY - USE AND MONITORING, The Medical clinics of North America, 82(3), 1998, pp. 601
Authors:
PETERSON P
HAYES TE
ARKIN CF
BOVILL EG
FAIRWEATHER RB
ROCK WA
TRIPLETT DA
BRANDT JT
Citation: P. Peterson et al., THE PREOPERATIVE BLEEDING-TIME TEST LACKS CLINICAL BENEFIT - COLLEGE-OF-AMERICAN-PATHOLOGISTS AND AMERICAN-SOCIETY-OF-CLINICAL-PATHOLOGISTSPOSITION ARTICLE, Archives of surgery, 133(2), 1998, pp. 134-139
Authors:
FAIRWEATHER RB
ANSELL J
VANDENBESSELAAR AMHP
BRANDT JT
BUSSEY HI
POLLER L
TRIPLETT DA
WHITE RH
Citation: Rb. Fairweather et al., COLLEGE-OF-AMERICAN-PATHOLOGISTS CONFERENCE XXXI ON LABORATORY MONITORING OF ANTICOAGULANT-THERAPY - LABORATORY MONITORING OF ORAL ANTICOAGULANT-THERAPY, Archives of pathology and laboratory medicine, 122(9), 1998, pp. 768-781
Authors:
ANSELL JE
BUTTARO ML
THOMAS IV
KNOWLTON CH
BECKER DM
BUSSEY HI
COREY R
GUMS JG
HUGHES R
JACOBSON A
KIRCHAIN W
KUHN K
LOKEN S
MCCAIN J
HALEY JA
OERTEL LB
THRASHER K
TRIPLETT DA
WHITCOMB H
WITTKOWSKY AK
ZARUS SA
Citation: Je. Ansell et al., CONSENSUS GUIDELINES FOR COORDINATED OUTPATIENT ORAL ANTICOAGULATION THERAPY MANAGEMENT, The Annals of pharmacotherapy, 31(5), 1997, pp. 604-615
Authors:
TRIPLETT DA
Citation: Da. Triplett, SIMULTANEOUS OCCURRENCE OF LUPUS ANTICOAGULANT AND FACTOR-VIII INHIBITORS, American journal of hematology, 56(3), 1997, pp. 195-196
Authors:
GEMPELERMESSINA PM
MULLER C
TRIPLETT DA
STOCKER KF
Citation: Pm. Gempelermessina et al., NEW SURROGATE POSITIVE CONTROL MATERIAL FOR LUPUS ANTICOAGULANT ASSAYS, Thrombosis and haemostasis, 1997, pp. 1363-1363
Authors:
YAMAZAKI M
ASAKURA H
AOSHIMA K
SAITO M
MATSUDA T
TRIPLETT DA
Citation: M. Yamazaki et al., PREDNISOLONE INHIBITS EODOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION AND IMPROVES MORTALITY IN RATS - IMPORTANCE OF INFLAMMATORY CYTOKINE SUPPRESSION, Blood, 90(10), 1997, pp. 3172-3172
Authors:
TRIPLETT DA
Citation: Da. Triplett, EVALUATION OF THE MINIMALLY PROLONGED APTT - PASSOVOY FACTOR OR LUPUSANTICOAGULANT, Journal of pediatric hematology/oncology, 18(3), 1996, pp. 247-248
Authors:
TRIPLETT DA
Citation: Da. Triplett, LUPUS ANTICOAGULANTS ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES - THE GREAT IMPOSTORS/, Lupus, 5(5), 1996, pp. 431-435
Authors:
TRIPLETT DA
Citation: Da. Triplett, ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES - CLINICAL USE OF LABORATORY TEST-RESULTS (IDENTIFICATION, PREDICTIVE VALUE, TREATMENT), Haemostasis, 26, 1996, pp. 358-367
Authors:
HOAGLAND LE
TRIPLETT DA
PENG F
BARNA L
Citation: Le. Hoagland et al., APC-RESISTANCE AS MEASURED BY A TEXTARIN TIME ASSAY - COMPARISON TO THE APTT-BASED METHOD, Thrombosis research, 83(5), 1996, pp. 363-373
Authors:
IGARASHI M
MATSUURA E
IGARASHI Y
NAGAE H
ICHIKAWA K
TRIPLETT DA
KOIKE T
Citation: M. Igarashi et al., HUMAN BETA(2) GLYCOPROTEIN I AS AN ANTICARDIOLIPIN COFACTOR DETERMINED USING DELETED MUTANTS EXPRESSED BY A BACULOVIRUS SYSTEM, Blood, 87(8), 1996, pp. 3262-3270
FREQUENT DIFFICULTIES ENCOUNTERED IN THE LABORATORY DIAGNOSIS OF ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES
Authors:
TRIPLETT DA
Citation: Da. Triplett, FREQUENT DIFFICULTIES ENCOUNTERED IN THE LABORATORY DIAGNOSIS OF ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES, Annales de medecine interne, 147, 1996, pp. 5-9
Authors:
MATSUURA E
IGARASHI M
IGARASHI Y
KATAHIRA T
NAGAE H
ICHIKAWA K
TRIPLETT DA
KOIKE T
Citation: E. Matsuura et al., MOLECULAR STUDIES ON PHOSPHOLIPID-BINDING SITES AND CRYPTIC EPITOPES APPEARING ON BETA(2)-GLYCOPROTEIN-I STRUCTURE RECOGNIZED BY ANTICARDIOLIPIN ANTIBODIES, Lupus, 4, 1995, pp. 13-17
Authors:
BRANDT JT
BARNA LK
TRIPLETT DA
Citation: Jt. Brandt et al., LABORATORY IDENTIFICATION OF LUPUS ANTICOAGULANTS - RESULTS OF THE 2ND INTERNATIONAL WORKSHOP FOR IDENTIFICATION OF LUPUS ANTICOAGULANTS - ON BEHALF OF THE SUBCOMMITTEE ON LUPUS ANTICOAGULANTS ANTIPHOSPHOLIPIDANTIBODIES OF THE ISTH, Thrombosis and haemostasis, 74(6), 1995, pp. 1597-1603
Authors:
BRANDT JT
TRIPLETT DA
ALVING B
SCHARRER I
Citation: Jt. Brandt et al., CRITERIA FOR THE DIAGNOSIS OF LUPUS ANTICOAGULANTS - AN UPDATE, Thrombosis and haemostasis, 74(4), 1995, pp. 1185-1190
Authors:
TRIPLETT DA
Citation: Da. Triplett, PROTEAN CLINICAL PRESENTATION OF ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES (APA), Thrombosis and haemostasis, 74(1), 1995, pp. 329-337
Authors:
BRANDT JT
TRIPLETT DA
BARNA L
AMIRAL J
Citation: Jt. Brandt et al., REACTIVITY OF ANTIPHOSPHOLIPID ANTIBODIES WITH PURIFIED PROTEINS IN ELISA ASSAYS, Thrombosis and haemostasis, 73(6), 1995, pp. 1265-1265
Authors:
TRIPLETT DA
Citation: Da. Triplett, ANTIPHOSPHOLIPID-PROTEIN ANTIBODIES - LABORATORY DETECTION AND CLINICAL RELEVANCE, Thrombosis research, 78(1), 1995, pp. 1-31
Authors:
POLLER L
TRIPLETT DA
HIRSH J
CARROLL J
CLARKE K
Citation: L. Poller et al., THE VALUE OF PLASMA CALIBRANTS IN CORRECTING COAGULOMETER EFFECTS ON INTERNATIONAL NORMALIZED RATIOS - AN INTERNATIONAL MULTICENTER STUDY, American journal of clinical pathology, 103(3), 1995, pp. 358-365
Authors:
POLLER L
TRIPLETT DA
HIRSH J
CARROLL J
CLARKE K
Citation: L. Poller et al., A COMPARISON OF LYOPHILIZED ARTIFICIALLY DEPLETED PLASMAS AND LYOPHILIZED PLASMAS FROM PATIENTS RECEIVING WARFARIN IN CORRECTING FOR COAGULOMETER EFFECTS ON INTERNATIONAL NORMALIZED RATIOS, American journal of clinical pathology, 103(3), 1995, pp. 366-371